12/1
08:52 am
stro
Sutro Biopharma Announces 1-for-10 Reverse Stock Split [Yahoo! Finance]
Medium
Report
Sutro Biopharma Announces 1-for-10 Reverse Stock Split [Yahoo! Finance]
12/1
08:00 am
stro
Sutro Biopharma Announces 1-for-10 Reverse Stock Split
High
Report
Sutro Biopharma Announces 1-for-10 Reverse Stock Split
11/26
02:19 pm
stro
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
11:04 am
stro
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day [Yahoo! Finance]
Low
Report
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day [Yahoo! Finance]
11/12
10:00 am
stro
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
Low
Report
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
11/7
11:30 pm
stro
Sutro Biopharma (NASDAQ:STRO) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $2.00 price target on the stock.
Low
Report
Sutro Biopharma (NASDAQ:STRO) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $2.00 price target on the stock.
11/6
06:34 pm
stro
Sutro Biopharma GAAP EPS of -$0.67 misses by $0.27, revenue of $9.69M beats by $0.56M [Seeking Alpha]
Medium
Report
Sutro Biopharma GAAP EPS of -$0.67 misses by $0.27, revenue of $9.69M beats by $0.56M [Seeking Alpha]
11/6
04:30 pm
stro
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
High
Report
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
11/5
04:05 pm
stro
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
Medium
Report
Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025
11/3
08:00 am
stro
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference
Medium
Report
Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference
10/25
12:12 pm
stro
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
03:45 pm
stro
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
9/29
05:16 pm
stro
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones [Yahoo! Finance]
Medium
Report
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones [Yahoo! Finance]
9/29
05:05 pm
stro
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
High
Report
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
9/29
06:36 am
stro
$3.65 Bn Click Chemistry and Bioorthogonal Chemistry Market Trends and Global Forecasts, 2040 [Yahoo! Finance]
Low
Report
$3.65 Bn Click Chemistry and Bioorthogonal Chemistry Market Trends and Global Forecasts, 2040 [Yahoo! Finance]